ADXN Addex Therapeutics
- 8.5400
- +0.5301+6.62%
Addex Therapeutics News
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | F-6 POS: Post-effective amendment to a F-6EF registration
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Addex Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
